Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy
Clinical Research in Cardiology · 2025
DOI: 10.1007/s00392-025-02665-w ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Ferenc Komlósi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Center, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Thrombosis, Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Semmelweis University.
Abstract (Originalsprache)
Background and aims Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Non-vitamin-K oral anticoagulants (NOACs) effectively reduce LAA thrombus prevalence and stroke risk. However, the optimal treatment of a NOAC-resistant thrombus remains unclear. We aimed to evaluate therapeutic strategies for resolving LAA thrombus in patients on optimal NOAC therapy.
Methods
We retrospectively analyzed patients scheduled for cardioversion or catheter ablation of AF between 2014 and 2023 with LAA thrombus on transesophageal echocardiography (TEE) despite being on optimal NOAC therapy. We assessed how the applied management strategy affected thrombus resolution.
Results
Among the analyzed 120 patients, a change to a different NOAC occurred in 41% of cases, a transition to a VKA in 30%, and the supplementation with antiplatelet therapy in 11%. In contrast, 18% of the patients received unchanged therapy. Follow-up imaging at 65 [44 – 95] days showed successful thrombus resolution in 92 (77%) of cases, predicted by a lower CHA2DS2-VASc score ( p = 0.01). Any modification of antithrombotic therapy was an independent predictor of thrombus resolution (OR 5.28 [1.55–18], p = 0.01). Of the four strategies, there was a trend toward better thrombus resolution with switching to a VKA (OR 3.23 [1.03–10.1], p = 0.04).
Conclusion
Resolution of LAA thrombus in patients already on adequate NOAC treatment may require a revision of the anticoagulation strategy. In addition, transitioning from NOAC to VKA might be considered. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
- Faculty of Medicine, Semmelweis University, Budapest, Hungary.
- Mater Private Hospital, Dublin, Ireland.
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary. nagyklaudiavivien@gmail.com.
Förderung
- National Research, Development and Innovation Office
- Semmelweis University
Zitieren
APA
Komlósi, F., Arnóth, B., Szakál, I., Tóth, P., Mészáros, H., Sánta, H., Bohus, G., Vámosi, P., Bartha, E., Horváth, M., Boussoussou, M., Szegedi, N., Salló, Z., Osztheimer, I., Perge, P., Széplaki, G., Gellér, L., Merkely, B., & Nagy, K. V. (2025). Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02665-w
Vancouver
Komlósi F, Arnóth B, Szakál I, Tóth P, Mészáros H, Sánta H, et al. Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02665-w
BibTeX
@article{Komlsi2025,
author = {Komlósi, Ferenc and Arnóth, Bence and Szakál, Imre and Tóth, Patrik and Mészáros, Henriette and Sánta, Helga and Bohus, Gyula and Vámosi, Péter and Bartha, Elektra and Horváth, Márton and Boussoussou, Melinda and Szegedi, Nándor and Salló, Zoltán and Osztheimer, István and Perge, Péter and Széplaki, Gábor and Gellér, László and Merkely, Béla and Nagy, Klaudia Vivien},
title = {Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy},
journal = {Clinical Research in Cardiology},
year = {2025},
doi = {10.1007/s00392-025-02665-w}
}
EUVIMED